C
Chris Holsinger
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Jun 14, 2026
Episode 14 [PART 2]: Chris Holsinger, the robot, E3311; the definitive piece
21:29
21:41
21:49
21:58
B
21:24BenHOST
deep margin i think having the deep margin on the list is important okay we're gonna get that yeah that's on the list

Chris HolsingerGUEST
but like for instance let's just restrict this to hpv medium or pharynx cancer let's take three types of tumors that we operate on what is the classic palatine tonsil tumor.

Chris HolsingerGUEST
The next is the glossopharyngeal sulcus tumor, and the third would be the tongue-based tumor.

Chris HolsingerGUEST
The details matter in this, but let's just take the palatine tonsil, for example.

Chris HolsingerGUEST
We use the word tonsil to refer to the palatine tonsil, but you could also refer to the tissue along the tongue base as lingual tonsil.
13 MINS LATER
W
35:15WillHOST
someone is guaranteed to have radiotherapy afterwards, yeah well I guess when you're seeing people and they have you know a burden of disease in the neck and you're saying to them look whatever happens here after surgery yeah you're going to need radiotherapy yeah should we be operating on those folks outside of the trial do you think that the biological information you get in like standard practice not in Stanford with lovely glass filled rooms in community oncology is enough to do that question